Bertram Kasiske, MD, FACP, (Work Group Chair) has a research grant from Merck; has lectured for Roche, Novartis, Wyeth, and Fujisawa; and has been a consultant to Wyeth and Novartis.
Fernando G. Cosio, MD, (Work Group Vice-Chair) has received grants from the Juvenile Diabetes Foundation and the National Kidney Foundation of Ohio.
Judith Beto, PhD, RD, FADA, has received grants from the National Kidney Foundation's Council on Renal Nutrition, the American Dietetic Association Foundation, and Dominican University, and is on the Scientific Advisory Board of R&D Laboratory, Marina del Ray, California.
Kline Bolton, MD, FACP, serves on the Advisory Boards for Amgen and Ortho-Biotech.
Blanche M. Chavers, MD, has received grants from the Department of Health and Human Services for the National Health and Nutrition Survey IV (NHANES), the US Renal Data System, and Roche Global Development.
Richard Grimm, Jr, MD, PhD, has received research funds or grants from Pfizer, Bristol-Myers Squibb, Merck, AstraZeneca, and Solvay.
Adeera Levin, MD, FRCPC, is on the Medical Advisory Board of Amgen Canada and Amgen USA, as well as Janssen Cilag International, Ortho Biotech Inc., Canada, and Roche International. She has received grants from the Kidney Foundation of Canada, BC Health Research Foundation, BC Transplant Foundation, Janssen Cilag International, Ortho Biotech, Amgen, and Genzyme, Inc.
Bassem Masri, MD, has received research funding from the National Institutes of Health as well as from Merck, AstraZeneca, Bristol-Myers Squibb, Sankyo, and Smith Kline Beecham (now GlaxoSmithKline).
Rulan Parekh, MD, MS, has received research funding from the Child Health Center of the National Institutes of Health, The Thomas Wilson Sanitarium, and the National Kidney Foundation of Maryland. She currently receives funding from the National Institutes of Diabetes and Digestive Disease (NIDDK) of the NIH.
Christoph Wanner, MD, has received research grants from Pfizer and Fresenius Medical Care (FMC) and lecture fees from Aventis, Roche, Merck, Janssen-Cilag, and FMC.
David C. Wheeler, MD, FRCP, currently receives research funding from the UK National Kidney Research Fund, the British Heart Foundation, the British Renal Society, and the Baxter Healthcare Extramural Grant Program. He has also received research funding from Merck and Amgen, has undertaken consultancy work for Fresenius, serves on the UK and European Advisory Boards of Genzyme, and has been paid lecture fees by Bristol-Myers Squibb, Novartis, Wyeth, and Fujisawa.
Peter W.F. Wilson, MD, has received research support from Roche Laboratories and served as a consultant to Lilly, Bayer, Bristol-Myers Squibb, Merck, Novartis, Pfizer, and Roche. He has also been a speaker for Merck, Pfizer, and Roche.